MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.18054

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2024

Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.

Hassanein Tarek, Keaveny Andrew P, Mantry Parvez, Smith Alastair D, McRae Michael P, Kittelson John, Helmke Steve, Everson Gregory T, SHUNT‐V Investigators

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The quantitative HepQuant SHUNT test of liver function and physiology generates a disease severity index (DSI) that correlates with risk for clinical complications, such as large oesophageal varices (LEVs). A derivative test, HepQuant DuO, generates an equivalent DSI and simplifies testing by requiring only oral administration of the test solution and two blood samples at 20 and 60 min.

AIMS: Since the DSIs measured from DuO and SHUNT are equivalent, we compared the diagnostic performance for large oesophageal varices (LEVs) between the DSIs measured from DuO and SHUNT tests.

METHODS

This study combined the data from two prospectively conducted US studies: HALT-C and SHUNT-V. A total of 455 subjects underwent both the SHUNT test and esophagogastroduodenoscopy (EGD).

RESULTS

DSI scores correlated with the probability of LEVs (p < 0.001) and demonstrated a stepwise increase from healthy lean controls without liver disease to subjects with chronic liver disease and no, small or large varices. Furthermore, a cutoff of DSI ≤ 18.3 from DuO had a sensitivity of 0.98 (missing only one case) and, if applied to the endoscopy (EGD) decision, would have prevented 188 EGDs (41.3%). The AUROC for DSI from DuO did not differ from that of the reference SHUNT test method (0.82 versus 0.81, p = 0.3500).

CONCLUSIONS

DSI from HepQuant DuO links liver function and physiology to the risk of LEVs across a wide spectrum of patient characteristics, disease aetiologies and liver disease severity. DuO is minimally invasive, easy to administer, quantitative and may aid the decision to avoid or perform EGD for LEVs.

Для цитирования: Hassanein Tarek, Keaveny Andrew P, Mantry Parvez, Smith Alastair D, McRae Michael P, Kittelson John, Helmke Steve, Everson Gregory T, SHUNT‐V Investigators. Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.. Alimentary pharmacology & therapeutics. 2024. DOI: 10.1111/apt.18054.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.